1. Home
  2. NOTE vs CLGN Comparison

NOTE vs CLGN Comparison

Compare NOTE & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FiscalNote Holdings Inc.

NOTE

FiscalNote Holdings Inc.

HOLD

Current Price

$1.90

Market Cap

39.9M

Sector

Technology

ML Signal

HOLD

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

HOLD

Current Price

$1.80

Market Cap

33.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOTE
CLGN
Founded
2013
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
EDP Services
Industrial Specialties
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.9M
33.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NOTE
CLGN
Price
$1.90
$1.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$29.25
$11.50
AVG Volume (30 Days)
238.6K
20.3K
Earning Date
11-06-2025
11-26-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$102,673,000.00
$2,475,000.00
Revenue This Year
N/A
$1,617.28
Revenue Next Year
$0.55
$83.54
P/E Ratio
N/A
N/A
Revenue Growth
N/A
280.77
52 Week Low
$1.83
$1.31
52 Week High
$24.36
$4.98

Technical Indicators

Market Signals
Indicator
NOTE
CLGN
Relative Strength Index (RSI) 27.09 37.94
Support Level $1.88 $1.77
Resistance Level $2.15 $2.08
Average True Range (ATR) 0.19 0.15
MACD 0.04 -0.02
Stochastic Oscillator 10.88 20.81

Price Performance

Historical Comparison
NOTE
CLGN

About NOTE FiscalNote Holdings Inc.

FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: